Department of Neurology, University of Ulm, Ulm, Germany.
AJNR Am J Neuroradiol. 2011 Aug;32(7):1328-32. doi: 10.3174/ajnr.A2514. Epub 2011 Jun 16.
The atrophy of the caudate is considered the hallmark of HD-associated neurodegeneration and has high potential as a biomarker in structural MR imaging. This study aimed at comparing automated and manual caudate volumetry.
In this cross-sectional volumetric study in 40 patients with HD and 30 healthy controls, a fully automated caudate measurement by ABV was used for the first time in HD and was directly compared with manual delineation as the generally accepted criterion standard of volumetry.
It could be shown that both techniques were able to separate patients and controls to a similar degree. The differences between the 2 volumetric measurements ranged within the limits of agreement; the systematically lower values by manual volumetry were caused by the different assessment of the dorsal caudate tail, which is hard to delineate manually.
ABV may be used instead of manual volumetry to quantify caudate volume loss. Additionally, the ABV technique has the advantage of being much faster, is less laborious, and is free of a subjective region-of interest definition. ABV might serve as a tool in potential future clinical trials of disease-modifying treatments in HD.
尾状核萎缩被认为是与 HD 相关的神经退行性变的标志,并且在结构磁共振成像 (MRI) 中作为生物标志物具有很高的潜力。本研究旨在比较自动和手动尾状核体积测量。
在这项横断面体积研究中,我们纳入了 40 名 HD 患者和 30 名健康对照者,首次在 HD 中使用 ABV 进行全自动尾状核测量,并将其与手动勾画作为体积测量的公认标准直接进行比较。
两种技术都能够以相似的程度将患者和对照组分开。两种体积测量方法之间的差异在一致性限度内;手动体积测量的系统较低值是由于手动勾画难以界定的尾状核背侧尾部的不同评估造成的。
ABV 可用于替代手动体积测量来定量尾状核体积丢失。此外,ABV 技术具有速度更快、更省力以及无主观感兴趣区定义的优点。ABV 可能成为 HD 疾病修饰治疗潜在未来临床试验的工具。